Joseph Rice
Director/Miembro de la Junta en BANC OF CALIFORNIA, INC. .
Fortuna: 493 951 $ al 30/04/2024
Cargos activos de Joseph Rice
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BANC OF CALIFORNIA, INC. | Director/Miembro de la Junta | 11/05/2023 | - |
Independent Dir/Board Member | 11/05/2023 | - | |
Nammi Therapeutics, Inc.
Nammi Therapeutics, Inc. BiotechnologyHealth Technology Nammi Therapeutics, Inc. specializes in prodrug design that allows for efficient and stable incorporation into nammisomes. The American company's technology maintains immune modulating agents in an inactive state until released by intracellular esterases, and provides IP and FTO. The private company was founded by David Stover. David Stover has been the CEO since incorporation. | Director de Operaciones | 01/01/2022 | - |
The Painted Turtle Camp Foundation | Director/Miembro de la Junta | - | - |
Music Center of | Director/Miembro de la Junta | - | - |
Historial de carrera de Joseph Rice
Antiguos cargos conocidos de Joseph Rice.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
WELLS FARGO & COMPANY | Corporate Officer/Principal | 01/01/2010 | 01/01/2016 |
Formación de Joseph Rice.
University of California, Los Angeles | Undergraduate Degree |
University of California, Berkeley | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 8 |
Operativa
Director/Board Member | 3 |
Independent Dir/Board Member | 1 |
Chief Operating Officer | 1 |
Sectorial
Finance | 3 |
Consumer Services | 3 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
WELLS FARGO & COMPANY | Finance |
BANC OF CALIFORNIA, INC. | Finance |
Empresas privadas | 3 |
---|---|
The Painted Turtle Camp Foundation | |
Music Center of | |
Nammi Therapeutics, Inc.
Nammi Therapeutics, Inc. BiotechnologyHealth Technology Nammi Therapeutics, Inc. specializes in prodrug design that allows for efficient and stable incorporation into nammisomes. The American company's technology maintains immune modulating agents in an inactive state until released by intracellular esterases, and provides IP and FTO. The private company was founded by David Stover. David Stover has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Joseph Rice
- Experiencia